Neil T. Sullivan

940 total citations
24 papers, 765 citations indexed

About

Neil T. Sullivan is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Neil T. Sullivan has authored 24 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Virology and 5 papers in Infectious Diseases. Recurrent topics in Neil T. Sullivan's work include HIV Research and Treatment (9 papers), CRISPR and Genetic Engineering (7 papers) and HIV/AIDS drug development and treatment (5 papers). Neil T. Sullivan is often cited by papers focused on HIV Research and Treatment (9 papers), CRISPR and Genetic Engineering (7 papers) and HIV/AIDS drug development and treatment (5 papers). Neil T. Sullivan collaborates with scholars based in United States, France and United Kingdom. Neil T. Sullivan's co-authors include Richard T. Wyatt, Jie Cao, J. Robinson, Cristina Parolin, J G Sodroski, James E. Robinson, Marshall R. Posner, H Repke, Markus Thali and Joseph Sodroski and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Neil T. Sullivan

24 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil T. Sullivan United States 15 477 288 259 229 95 24 765
Lindvi Gudmundsdotter Sweden 16 190 0.4× 293 1.0× 272 1.1× 118 0.5× 177 1.9× 30 678
Ashley P. Barry United States 15 686 1.4× 262 0.9× 609 2.4× 244 1.1× 27 0.3× 20 1.1k
Brandon Hogstad United States 5 246 0.5× 256 0.9× 390 1.5× 62 0.3× 47 0.5× 5 710
Tzu-Ling Sung United States 10 316 0.7× 443 1.5× 216 0.8× 221 1.0× 54 0.6× 11 794
Vincent Dussupt United States 15 227 0.5× 330 1.1× 124 0.5× 166 0.7× 15 0.2× 23 693
Claudia Arenaccio Italy 16 166 0.3× 673 2.3× 239 0.9× 203 0.9× 14 0.1× 24 816
Agnes E. Hamburger United States 13 63 0.1× 287 1.0× 262 1.0× 108 0.5× 122 1.3× 19 769
Ina Ambiel Germany 9 514 1.1× 284 1.0× 373 1.4× 210 0.9× 28 0.3× 12 789
Frank Wegmann Netherlands 13 82 0.2× 298 1.0× 269 1.0× 98 0.4× 34 0.4× 27 722
Mauro Di Pilato United States 12 180 0.4× 236 0.8× 452 1.7× 67 0.3× 13 0.1× 16 818

Countries citing papers authored by Neil T. Sullivan

Since Specialization
Citations

This map shows the geographic impact of Neil T. Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil T. Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil T. Sullivan more than expected).

Fields of papers citing papers by Neil T. Sullivan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil T. Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil T. Sullivan. The network helps show where Neil T. Sullivan may publish in the future.

Co-authorship network of co-authors of Neil T. Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Neil T. Sullivan. A scholar is included among the top collaborators of Neil T. Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil T. Sullivan. Neil T. Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Azari, Feredun, Gregory T. Kennedy, Ian W. Folkert, et al.. (2025). A fibroblast activation protein targeted optical tracer for identifying primary and metastatic sarcoma during resection. EJNMMI Research. 15(1). 94–94. 1 indexed citations
2.
Singhal, Sunil, Abhishek S. Rao, Jason Stadanlick, et al.. (2024). Human Tumor–Associated Macrophages and Neutrophils Regulate Antitumor Antibody Efficacy through Lethal and Sublethal Trogocytosis. Cancer Research. 84(7). 1029–1047. 16 indexed citations
3.
Azari, Feredun, R.P. Meijer, Gregory T. Kennedy, et al.. (2023). Carcinoembryonic Antigen–Related Cell Adhesion Molecule Type 5 Receptor–Targeted Fluorescent Intraoperative Molecular Imaging Tracer for Lung Cancer. JAMA Network Open. 6(1). e2252885–e2252885. 11 indexed citations
4.
Kennedy, Gregory T., David E. Holt, Feredun Azari, et al.. (2022). A Cathepsin-Targeted Quenched Activity–Based Probe Facilitates Enhanced Detection of Human Tumors during Resection. Clinical Cancer Research. 28(17). 3729–3741. 28 indexed citations
5.
Kennedy, Gregory T., Feredun Azari, Elizabeth Bernstein, et al.. (2022). A Prostate-Specific Membrane Antigen—Targeted Near-Infrared Conjugate for Identifying Pulmonary Squamous Cell Carcinoma during Resection. Molecular Cancer Therapeutics. 21(4). 546–554. 14 indexed citations
6.
Kennedy, Gregory T., Feredun Azari, Elizabeth Bernstein, et al.. (2022). Targeted detection of cancer at the cellular level during biopsy by near-infrared confocal laser endomicroscopy. Nature Communications. 13(1). 2711–2711. 18 indexed citations
7.
Azari, Feredun, Gregory T. Kennedy, Neil T. Sullivan, et al.. (2022). Presence of non-Newtonian fluid in invasive pulmonary mucinous adenocarcinomas impacts fluorescence during intraoperative molecular imaging of lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 49(13). 4406–4418. 4 indexed citations
8.
Azari, Feredun, Gregory T. Kennedy, Elizabeth Bernstein, et al.. (2022). Glycoprotein Receptor CEACAM5-Targeted Intraoperative Molecular Imaging Tracer in Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery. 116(3). 631–641. 6 indexed citations
9.
Azari, Feredun, Gregory T. Kennedy, Patrick Bou‐Samra, et al.. (2022). Sodium Multivitamin Transporter-Targeted Fluorochrome Facilitates Enhanced Metabolic Evaluation of Tumors Through Coenzyme-R Dependent Intracellular Signaling Pathways. Molecular Imaging and Biology. 25(3). 569–585. 3 indexed citations
10.
Kennedy, Gregory T., Feredun Azari, Elizabeth Bernstein, et al.. (2022). Targeted detection of cancer cells during biopsy allows real-time diagnosis of pulmonary nodules. European Journal of Nuclear Medicine and Molecular Imaging. 49(12). 4194–4204. 15 indexed citations
11.
Lu, Zhen, Jinyun Chen, Pengfei Yu, et al.. (2022). Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancer. Nature Communications. 13(1). 6623–6623. 23 indexed citations
12.
Cooke, Mariana, Martin J. Baker, Suli Zhang, et al.. (2021). FARP1, ARHGEF39, and TIAM2 are essential receptor tyrosine kinase effectors for Rac1-dependent cell motility in human lung adenocarcinoma. Cell Reports. 37(5). 109905–109905. 29 indexed citations
13.
Sullivan, Neil T., Alexander G. Allen, Andrew Atkins, et al.. (2020). Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing. Frontiers in Microbiology. 11. 1872–1872. 12 indexed citations
14.
Chung, Cheng-Han, Alexander G. Allen, Andrew Atkins, et al.. (2020). Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites. Molecular Therapy — Nucleic Acids. 21. 965–982. 15 indexed citations
15.
Chung, Cheng-Han, Alexander G. Allen, Neil T. Sullivan, et al.. (2019). Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency. Molecular Therapy. 28(1). 19–28. 26 indexed citations
16.
Sullivan, Neil T., Will Dampier, Cheng-Han Chung, et al.. (2019). Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients. Scientific Reports. 9(1). 17088–17088. 24 indexed citations
17.
Dampier, Will, Neil T. Sullivan, Joshua Chang Mell, et al.. (2018). Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics. AIDS Research and Human Retroviruses. 34(11). 950–960. 26 indexed citations
18.
Dampier, Will, Neil T. Sullivan, Cheng-Han Chung, et al.. (2017). Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants. Scientific Reports. 7(1). 14413–14413. 29 indexed citations
19.
Datta, Prasun K., Rafal Kaminski, Wenhui Hu, et al.. (2016). HIV-1 Latency and Eradication: Past, Present and Future. Current HIV Research. 14(5). 431–441. 30 indexed citations
20.
Aiamkitsumrit, Benjamas, Neil T. Sullivan, Michael R. Nonnemacher, Vanessa Pirrone, & Brian Wigdahl. (2015). Human Immunodeficiency Virus Type 1 Cellular Entry and Exit in the T Lymphocytic and Monocytic Compartments. Advances in virus research. 93. 257–311. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026